Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2008
A phase II clinical trial of sorafenib in androgen-independent prostate cancer
William L Dahut, Charity Scripture, Edwin Posadas, et al.
Frontiers in Oncology
|
July 9, 2020
Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer
Kristen P Zeligs, Maria Pia Morelli, Justin M David, et al.
Cancer Biology & Therapy
|
September 3, 2005
A phase II study of perifosine in androgen independent prostate cancer
Edwin M Posadas, James Gulley, Philip M Arlen, et al.
The Journal of Urology
|
August 21, 2007
Clinical safety of a viral vector based prostate cancer vaccine strategy
Philip M Arlen, Lisa Skarupa, Mary Pazdur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
James L Gulley, Philip M Arlen, Kwong-Yok Tsang, et al.
European Urology Oncology
|
October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide
Shruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.
JAMA Oncology
|
August 21, 2015
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial
Christopher R Heery, Nuhad K Ibrahim, Philip M Arlen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2011
A pilot study of MUC-1/CEA/TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancer
Mahsa Mohebtash, Kwong-Yok Tsang, Ravi A Madan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer
Yang-Min Ning, James L Gulley, Philip M Arlen, et al.
The Oncologist
|
May 3, 2023
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer
Ravi A Madan, Marijo Bilusic, Mark N Stein, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2008
A phase II clinical trial of sorafenib in androgen-independent prostate cancer
William L Dahut, Charity Scripture, Edwin Posadas, et al.
Frontiers in Oncology
|
July 9, 2020
Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer
Kristen P Zeligs, Maria Pia Morelli, Justin M David, et al.
Cancer Biology & Therapy
|
September 3, 2005
A phase II study of perifosine in androgen independent prostate cancer
Edwin M Posadas, James Gulley, Philip M Arlen, et al.
The Journal of Urology
|
August 21, 2007
Clinical safety of a viral vector based prostate cancer vaccine strategy
Philip M Arlen, Lisa Skarupa, Mary Pazdur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
James L Gulley, Philip M Arlen, Kwong-Yok Tsang, et al.
European Urology Oncology
|
October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide
Shruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.
JAMA Oncology
|
August 21, 2015
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial
Christopher R Heery, Nuhad K Ibrahim, Philip M Arlen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2011
A pilot study of MUC-1/CEA/TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancer
Mahsa Mohebtash, Kwong-Yok Tsang, Ravi A Madan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer
Yang-Min Ning, James L Gulley, Philip M Arlen, et al.
The Oncologist
|
May 3, 2023
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer
Ravi A Madan, Marijo Bilusic, Mark N Stein, et al.
Page
of 9